Medizinische Universität Graz - Research portal
Stefulj Jasminka |
Presentations at scientific and public conferences
George, M; Gali, CC; Fanaee-Danesh, E; Tam-Amersdorfer, C; Stracke, A; Strutz, J; Leopold, B; Stefulj, J; Wadsack, C; Desoye, G; Zimmermann, R; Panzenboeck, U
Synthetic and endogenous liver-X receptor ligands differentially modulate a pro-inflammatory phenotype observed in human fetoplacental endothelial cells in Gestational diabetes mellitus
47th Annual Meeting, ÖGAI 2019; NOV 21-23; Graz, AUSTRIA. 2019.
[Poster]
FullText
George, M; Gali,CC; Fanaee-Danesh, E; Tam-Amersdorfer, C; Stracke, A; Strutz, J; Leopold, B; Zimmermann, R; Stefulj, J; Desoye, G; Wadsack, C; Panzenboeck, U
Synthetic and endogenous liver-X receptor ligands differentially modulate a pro-inflammatory phenotype observed in human fetoplacental endothelial cells in Gestational diabetes mellitus
Doctoral Day MUG 2019; NOV 21; Graz, AUSTRIA. 2019.
[Poster]
FullText
Chirackal Manavalan, AP; Kober, A; Metso, J; Lang, I; Zandl, M; Fanaee Danesh, E; Pippal, JB; Stefulj, J; Jauhiainen, M; Panzenboeck, U
Phospholipid transfer protein is expressed in cerebrovascular endothelial cells and involved in biogenesis and remodeling of high-density lipoproteins at the blood-brain barrier.
The 8th International Congress on Vascular Dementia & the First Cognitive Impairment European Meeting; OCT 17-20; Athens, GREECE. 2013.
[Poster]
Manavalan, APC; Becker, T; Hasslitzer, K; Schweinzer, C; Scholler, M; Kober, A; Stefulj, J; Panzenboeck, U
Liver X receptor activation enhances phospholipid transfer protein (PLTP)
expression and activity in cerebrovascular endothelial cells of the blood brain
barrier.
18th ANNUAL MEETING - AAS
of the Austrian Atherosclerosis Society; MAY 6-7, 2011; St. Gilgen, AUSTRIA. 2011.
[Oral Communication]
Manavalan, APC; Scholler, M; Becker, T; Hasslitzer, K; Kober, A; Schweinzer, C; Stefulj, J; Panzenboeck, U
Regulation of the expression and activity of phospholipid transfer protein (PLTP) in capillary endothelial cells of the blood brain barrier by Liver X receptor
3rd Austrian Association of Molecular Life Sciences and Biotechnology (ÖGMBT) Annual Meeting 2011; 28 to 30 September 2011; Salzburg, AUSTRIA. 2011.
[Poster]
Stefulj, J; Malnar, M; Schweinzer, C; Kosicek, M; Zivkovic, J; Panzenboeck, U; Hecimovic, S
The impacts of LXR ligand TO901317 on amyloid-beta levels and cholesterol metabolism in Niemann-Pick type C disease model cells.
Alzheimer's Association 2011 International Conference on Alzheimer's Disease (ICAD 2011); JUL 16-21; Paris, FRANCE. 2011.
[Poster]
Panzenboeck, U; Stefulj, J; Schweinzer, C; Wadsack, C; Moertl, M; Desoye, G
Cholesterol efflux mechanisms in endothelial cells of the human placenta
REPROD SCI. 2008; 15(2): 92A-92A.
[Poster]
Web of Science
Stefulj, J; Becker,T; Hirschmugl,B; Schweinzer, C; Hasslitzer, K; Marsche, G; Desoye,G; Wadsack,C and Panzenboeck, U
ABCA1 and ABCG1 are operative in fetal endothelial cells of the human placenta
2nd International Graz Symposium on Lipid and Membrane Biology: Focus on Lipotoxicity; March 13.-15, 2008; Graz, Austria. 2008.
[Poster]
Desoye, G; Stefujl, J; Schweinzer, C; Panzenboeck, U; Wadsack, C;
Cholesterol Efflux In Human Placental Endothelial Cells.
Placenta2007; 28(8-9):A26-A26.-International Federation of Placenta Association Meeting ; AUG 17-22, 2007; Kingston, Ontario, CANADA.
[Poster]
Web of Science
Panzenboeck, U; Stefujl, J; Schweinzer, C; Desoye, G; Wadsack, C
Cholesterol efflux mechanisms in fetal endothelial cells of the human placenta.
14. Jahrestagung der Österreichischen Atherosklerosegesellschaft (AAS); Mai 11-12, 2007; St. Gilgen, AUSTRIA. 2007.
[Oral Communication]
Panzenboeck, U; Stefulj, J; Schweinzer, C; Desoye, G; Wadsack, C
CHOLESTEROL EFFLUX MECHANISMS IN ENDOTHELIAL CELLS OF THE HUMAN PLACENTA.
Journal of Clinical Lipidology2007; 1(5):356--XVI International Symposium on DRUGS AFFECTING LIPID METABOLISM; OCT 4-7, 2007; New York, USA.
[Oral Communication]
Stefulj, J; Schweinzer, C; Reicher, H; Calayir, E; Kratzer, A; Kratky, D; Kostner, GM; Sattler, W; Panzenboeck, U
LXR activation regulates target genes involved in cholesterol turnover, while steady-state lipid homeostasis in the CNS is maintained.
14. Jahrestagung der Österreichischen Atherosklerosegesellschaft (AAS); MAY 11-12, 2007; St. Gilgen, AUSTRIA. 2007.
[Poster]
Stefulj, J; Schweinzer, C; Reicher, H; Calayir, E; Kratzer, A; Sattler, W; Panzenboeck, U
ACTIVATION OF LIVER X RECEPTORS IN THE BRAIN: REGULATION OF TARGET GENE EXPRESSION WITHOUT DISTURBING STEADY-STATE LIPID HOMEOSTASIS
Journal of Clinical Lipidology2007; 1(5):459-459.-XVI International Symposium on DRUGS AFFECTING LIPID METABOLISM; OCT 4-7, 2007; New York, USA.
[Poster]